Mouse Anti-CPA4 Recombinant Antibody (1F4) (V2LY-1206-LY921)

Wang, Y., Xie, Y., Niu, Y., Song, P., Liu, Y., Burnett, J., ... & Sun, L. (2021). Carboxypeptidase A4 negatively correlates with p53 expression and regulates the stemness of breast cancer cells. International Journal of Medical Sciences, 18(8), 1753.

Wei, C., Zhou, Y., Xiong, Q., Xiong, M., Hou, Y., Yang, X., & Chen, Z. (2021). Comprehensive Analysis of CPA4 as a Poor Prognostic Biomarker Correlated with Immune Cells Infiltration in Bladder Cancer. Biology, 10(11), 1143.

Gao, W., Guo, N., Zhao, S., Chen, Z., Zhang, W., Yan, F., ... & Chi, K. (2020). Carboxypeptidase A4 promotes cardiomyocyte hypertrophy through activating PI3K-AKT-mTOR signaling. Bioscience reports, 40(5).

Moon, Y., Moon, R., Roh, H., Chang, S., Lee, S., & Park, H. (2020). HIF-1α-dependent induction of carboxypeptidase A4 and carboxypeptidase E in hypoxic human adipose-derived stem cells. Molecules and Cells, 43(11), 945.

Shao, Q., Zhang, Z., Cao, R., Zang, H., Pei, W., & Sun, T. (2020). CPA4 promotes EMT in pancreatic cancer via stimulating PI3K-AKT-mTOR signaling. OncoTargets and therapy, 13, 8567.

Handa, T., Katayama, A., Yokobori, T., Yamane, A., Fujii, T., Obayashi, S., ... & Oyama, T. (2019). Carboxypeptidase A4 accumulation is associated with an aggressive phenotype and poor prognosis in triple-negative breast cancer. International journal of oncology, 54(3), 833-844.

Bademler, S., Ucuncu, M. Z., Tilgen Yasasever, C., Serilmez, M., Ertin, H., & Karanlık, H. (2019). Diagnostic and prognostic significance of carboxypeptidase A4 (CPA4) in breast cancer. Biomolecules, 9(3), 103.

Zhang, H., Hao, C., Wang, H., Shang, H., & Li, Z. (2019). Carboxypeptidase A4 promotes proliferation and stem cell characteristics of hepatocellular carcinoma. International Journal of Experimental Pathology, 100(2), 133-138.

Pan, H., Pan, J., Ji, L., Song, S., Lv, H., Yang, Z., & Guo, Y. (2019). Carboxypeptidase A4 promotes cell growth via activating STAT3 and ERK signaling pathways and predicts a poor prognosis in colorectal cancer. International journal of biological macromolecules, 138, 125-134.

Fu, Y., Su, L., Cai, M., Yao, B., Xiao, S., He, Q., ... & Huang, X. (2019). Downregulation of CPA4 inhibits non small–cell lung cancer growth by suppressing the AKT/c‐MYC pathway. Molecular carcinogenesis, 58(11), 2026-2039.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols